Close
24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.

Read the full press release published by the ALBA Synchrotron

More news

13/04/2023 Panattoni acquires 60,000 sqm land plot to build a data center 16/09/2021 Battery technology in the Barcelona Synchrotron Park environment 06/09/2021 Advances in the creation of a state-of-the-art microscopy platform at the Alba Synchrotron 22/07/2021 IBM, the big blue of technology at the Barcelona Synchrotron Park 02/07/2021 SENER, cutting-edge engineering and technology in the Barcelona Synchrotron Park 11/06/2021 Parc de l'Alba: first injection of landfill gas into the distribution network
1 2 3 4 5 6